Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 4, 2012, Pages 378-392

  Kalmar, Bernadett ^a   Edet Amana, Emem ^a   Greensmith, Linda ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AChE; ALS; ChAT; Heat shock protein; Muscle denervation; Neuromuscular junction; Synaptic enzyme

Indexed keywords

ACETYLCHOLINESTERASE; ARIMOCLOMOL; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 70; SILVER CHOLINESTERASE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTENSOR DIGITORUM LONGUS MUSCLE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MOUSE; MUSCLE DENERVATION; MUSCLE INNERVATION; NERVE SPROUTING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; SOLEUS MUSCLE; SPINAL CORD; TIBIALIS ANTERIOR MUSCLE;

ACETYLCHOLINESTERASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GPI-LINKED PROTEINS; HEAT-SHOCK RESPONSE; HSP70 HEAT-SHOCK PROTEINS; HYDROXYLAMINES; LONGITUDINAL STUDIES; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

EID: 84861642581     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.660953     Document Type: Article

References (50)

1. Blijham PJ, Schelhaas HJ, Ter Laak HJ, van Engelen BG, Zwarts MJ. Early diagnosis of ALS: The search for signs of denervation in clinically normal muscles. J Neurol Sci. 2007;15;154-7.
2. Maselli RA, Wollman RL, Leung C, Distad B, Palombi S, Richman DP, et al. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16: 1193-203.
3. Gordon T, Hegedus J, Tam SL. Adaptive and maladaptive motor axonal sprouting in aging and motor neuron disease. Neurol Res. 2004;26:174-85.
4. Pinelli P, Pisano F, Ceriani F, Miscio G. EMG evaluation of motor neuron sprouting in amyotrophic lateral sclerosis. Ital J Neurol Sci. 1991;12:359-67.
5. Tsujihata M, Hazama R, Yoshimura T, Satoh A, Mori M, Nagataki S. The motor endplate fi ne structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve. 1984;7:243-9.
6. Fernandez HL, Stiles JR, Donoso JA. Skeletal muscle acetylcholinesterase molecular forms in amyotrophic lateral sclerosis. Muscle Nerve. 1986;9:399-406.
7. Yoshihara T, Ishii T, Iwata M, Nomoto M. Ultrastructural and histochemical study of the motor endplates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis. Ultrastruct Pathol. 1998;22:121-6.
8. Berger ML, Veitl M, Malessa S, Sluga E, Hornykiewicz O. Cholinergic markers in ALS spinal cord. J Neurol Sci. 1992;108:114-7.
9. Gonzalez De Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, Loeffl er JP, et al. Amyotrophic lateral sclerosis: All roads lead to Rome. J Neurochem. 2007; 101:1153-60.
10. Boillee S, Vande VC, Cleveland DW. ALS: A disease of motor neurons and their non-neuronal neighbours. Neuron. 2006;52:39-59.
11. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, et al. Wild-type non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113-7.
12. Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-Autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2006;103:19546-51.
13. Dobrowolny G, Aucello M, Rizzuto E, Beccafi co S, Mammucari C, Boncompagni S, et al. Skeletal muscle is a primary target of SOD1-G93A-mediated toxicity. Cell Metab. 2008;8:425-36.
14. Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet. 2010;19:2284-302.
15. Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, et al. A mutation in dynein rescues axonal transport defects and extends the lifespan of ALS mice. J Cell Biol. 2005;169:561-7.
16. Durand J, Amendola J, Bories C, Lamotte DB. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J Physiol Paris. 2006;99:211-20.
17. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol. 2004;185:232-40.
18. Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motor neuron axons in motor neuron disease alleviated by CNTF. Nat Neurosci. 2006;9:408-19.
19. Saxena S, Cabuy E, Caroni P. A role for motor neuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627-36.
20. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motor neuron diseases. J Neurosci. 2000;20:2534-42.
21. Kalmar B, Novoselov S, Gray A, Cheetham ME, Margulis B, Greensmith L. Late-stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J Neurochem. 2008;107:339-50.
22. De WF, Vo T, Stam FJ, Wisman LA, Bar PR, Niclou SP, et al. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci. 2006;32:102-17.
23. Dengler R, Konstanzer A, Kuther G, Hesse S, Wolf W, Struppler A. Amyotrophic lateral sclerosis: Macro-EMG and twitch forces of single motor units. Muscle Nerve. 1990; 13:545-50.
24. Kuncl RW, Cornblath DR, Griffi n JW. Assessment of thoracic paraspinal muscles in the diagnosis of ALS. Muscle Nerve. 1988;11:484-92.
25. Telerman-Toppet N, Coers C. Motor innervation and fi bre type pattern in amyotrophic lateral sclerosis and in Charcot-Marie-Tooth disease. Muscle Nerve. 1978;1:133-9
26. Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med. 2004;10:402-5.
27. Hargitai J, Lewis H, Boros I, Racz T, Fiser A, Kurucz I, et al. Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun. 2003;307:689-95.
28. Gurney ME. Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med. 1994;22:1721-2.
29. Namba T, Nakamura T, Grob D. Staining for nerve fi bre and cholinesterase activity in fresh frozen sections. Am J Clin Pathol. 1967;47:74-7.
30. Brown MC, Ironton R. Sprouting and regression of neuromuscular synapses in partially denervated mammalian muscles. J Physiol. 1978;278:325-48.
31. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem. 1975;24:407-9.
32. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7: 88-95.
33. Nostrandt AC, Duncan JA, Padilla S. A modifi ed spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam Appl Toxicol. 1993;21:196-203.
34. Harris JB, Ribchester RR. The relationship between endplate size and transmitter release in normal and dystrophic muscles of the mouse. J Physiol. 1979;296:245-65.
35. Sharp PS, Dick JR, Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Neuroscience. 2005;130:897-910.
36. Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008; 586:3337-51.
37. Crochemore C, Pena-Altamira E, Virgili M, Monti B, Contestabile A. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice. Neurochem Int. 2005;46:357-68.
38. Oda Y. Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathol Int. 1999;49:921-37.
39. Tateno M, Kato S, Sakurai T, Nukina N, Takahashi R, Araki T. Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum Mol Genet. 2009;18:942-55.
40. David G, Nguyen K, Barrett EF. Early vulnerability to ischaemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp Neurol. 2007;204:411-20.
41. Dadon-Nachum M, Melamed E, Offen D. The 'd ying-back' phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470-7.
42. Souayah N, Coakley KM, Chen R, Ende N, McArdle JJ. Defective Neuromuscular Transmission in the SOD1-G93A Transgenic Mouse Improves After Administration of Human Umbilical Cord Blood Cells. Stem Cell Rev. 2011 Jun 16.
43. Dupuis L, Loeffl er JP. Neuromuscular junction destruction during amyotrophic lateral sclerosis: Insights from transgenic models. Curr Opin Pharmacol. 2009;9:341-6.
44. Towne C, Raoul C, Schneider BL, Aebischer P. Systemic AAV6 delivery mediating RNA interference against SOD1: Neuromuscular transduction does not alter disease progression in FALS mice. Mol Ther. 2008;16:1018-25.
45. Jokic N, Gonzalez De Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol. 2005;57:553-6.
46. Jokic N, Gonzalez De Aguilar JL, Dimou L, Lin S, Fergani A, Ruegg MA, et al. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 2006;7:1162-7.
47. Pradat PF, Bruneteau G, Gonzalez De Aguilar JL, Dupuis L, Jokic N, Salachas F, et al. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol. 2007;62:15-20.
48. Dupuis L, Oudart H, Rene F, Gonzalez De Aguilar JL, Loeffl er JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefi t of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159-64.
49. Kalmar B, Burnstock G, Vrbova G, Urbanics R, Csermely P, Greensmith L. Up-regulation of heat shock proteins rescues motor neurons from axotomy-induced cell death in neonatal rats. Exp Neurol. 2002;176:87-97.
50. Vigh L, Literati PN, Horvath I, Torok Z, Balogh G, Glatz A, et al. Bimoclomol: A non-toxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med. 1997;3:1150-4.